Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W L Furman

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Blood|December 1, 1986
Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemiaC H Pui, S C Raimondi, F G Behm, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.
Journal of Pediatric Hematology/Oncology|March 3, 1998
Thrombopoietin level in young patients is related to megakaryocyte frequency and platelet countM U Kuefer, W C Wang, D R Head, et al.
Investigational New Drugs|January 1, 1996
Topoisomerase I interactive drugs in children with cancerC F Stewart, W C Zamboni, W R Crom, et al.
Medical and Pediatric Oncology|January 1, 1994
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapyN M Marina, S J Shema, L C Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecanM K Ma, W C Zamboni, K M Radomski, et al.
Medical and Pediatric Oncology|January 1, 1994
Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphomaJ T Sandlund, R Ribeiro, J S Lin, et al.
Cancer|December 1, 1996
Overt testicular disease at diagnosis is associated with high risk features and a poor prognosis in patients with childhood acute lymphoblastic leukemiaA Gajjar, R C Ribeiro, H H Mahmoud, et al.
Blood|May 15, 1989
Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemiaC H Pui, S C Raimondi, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988L C Bowman, M L Hancock, V M Santana, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Blood|December 1, 1986
Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemiaC H Pui, S C Raimondi, F G Behm, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.
Journal of Pediatric Hematology/Oncology|March 3, 1998
Thrombopoietin level in young patients is related to megakaryocyte frequency and platelet countM U Kuefer, W C Wang, D R Head, et al.
Investigational New Drugs|January 1, 1996
Topoisomerase I interactive drugs in children with cancerC F Stewart, W C Zamboni, W R Crom, et al.
Medical and Pediatric Oncology|January 1, 1994
Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapyN M Marina, S J Shema, L C Bowman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecanM K Ma, W C Zamboni, K M Radomski, et al.
Medical and Pediatric Oncology|January 1, 1994
Factors contributing to the prognostic significance of bone marrow involvement in childhood non-Hodgkin lymphomaJ T Sandlund, R Ribeiro, J S Lin, et al.
Cancer|December 1, 1996
Overt testicular disease at diagnosis is associated with high risk features and a poor prognosis in patients with childhood acute lymphoblastic leukemiaA Gajjar, R C Ribeiro, H H Mahmoud, et al.
Blood|May 15, 1989
Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemiaC H Pui, S C Raimondi, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988L C Bowman, M L Hancock, V M Santana, et al.
Pageof 6